MedTrace Logo

Esophageal Monitoring Device for Assessing Mucosal Impedance

NCT01556919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 429

Last updated 2021-08-03

No results posted yet for this study

Summary

The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, each designed to measure at slightly different spacing on the esophagus.

Conditions

  • GERD
  • Esophagitis

Interventions

PROCEDURE

Standard of care endoscopy

standard of care endoscopy

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2021-07-23
Completion
2021-07-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01556919 on ClinicalTrials.gov